[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6688 

# __Delayed availability of treatments due to extensive scientific checks and clinical trials__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Streamline and expedite the approval process for potential treatments](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8562.md)

## Name of the risk

Delay in providing effective treatment to COVID-19 patients

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)

## Stakeholders who can mitigate this risk

* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)

## Technologies linked to the risk

* [Clinical trial management systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_7998.md)
* [Regulatory technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8138.md)

## This Risk belongs to this RiskGroup

* [Economic risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_5.md)

## This Risk belongs to this RiskSubgroup

* [Discontinuity of services](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_26.md)

